FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

Posted on December 24, 2024 by

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

Trump says U.S. will have ‘golden share’ in U.S. Steel after Nippon deal